Visual field defect associated with vigabatrin: observational cohort study.
Wilton
L V
LV
Drug Safety Research Unit, Southampton SO31 1AA. admin@dsru.u-net.com
Stephens
M D
MD
Mann
R D
RD
D000328:Adult; D000927:Anticonvulsants / Q000009:adverse effects*; D015331:Cohort Studies; D004791:Enzyme Inhibitors / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012307:Risk Factors; D020888:Vigabatrin / Q000009:adverse effects*; D014786:Vision Disorders / Q000139:chemically induced*; D014794:Visual Fields / Q000187:drug effects*
D000927:Anticonvulsants; D004791:Enzyme Inhibitors; D020888:Vigabatrin